Stopping Preventable Harm. Backed by Over 20 Years of Proven Outcomes.
GlytecOne makes metabolic management safe and measurable.
Hospitals use GlytecOne to standardize metabolic care, surface risk before it becomes harm, and prove measurable outcomes before CMS makes them public.
Health Plans use GlytecOne to close the metabolic care gap for inpatient and post-discharge to close Stars and HEDIS measure gaps for health plan members.
400+
hospital clients
100+
patents
16 years
of innovation
50B+
data points
FDA-cleared
Glucommander®
Introducing GlytecOne: For Every Hospital. For Every Patient.
The first unified glycemic management platform that integrates clinical decision support, workflow automation, performance analytics, and enterprise population health intelligence. GlytecOne connects every care team member and hospital leader with the data and tools to help deliver safer, more consistent glucose management across your entire health system.
Care Enablement
FDA-cleared insulin dosing guidance and standardized clinical workflows.
Decision Support
Current patient visibility and structured clinical review through Command Center.
Performance Insights
Enterprise analytics, benchmarking, and eCQM-aligned reporting through Command Center.
Population Health
Enterprise-wide glycemic intelligence for health system leaders and health plan partners.
Stop High-Risk Manual Protocols.
Start Delivering Safer Glycemic Care.
CLIENTS

The Intelligent Glycemic Management Platform
Watch our Video
Are You CMS eCQM Ready?
CMS now requires hospitals to report severe hypoglycemia and severe hyperglycemia as hospital harm eCQMs. The 2026 measurement period is active. Is your organization prepared?
Measurement period began January 1, 2026
Days remaining in the 2026 measurement period.
Featured Case Study
Riverside Healthcare Saved More than $2.6 million Annually
Glytec’s Numbers Speak for Themselves
GlytecOne helps hospitals reduce glycemic variability, supports safer insulin management, and strengthens performance across clinical, operational, and financial measures.
- 6-8x ROI
- 62% Improvement over Competition
- $10k+ Avg Cost Savings per Severe Hypo Event
- 47% Nurse Time Savings
- 30 minper Shift Savings*
- 90% Satisfaction
- 99.8% Reduction in Inpatient Hypoglycemia
- 3.1% Reduction in A1C
- 68% Reduction in 30-Day Readmissions**
*Up to 30 minutes **Up to 68%
What Glytec Partners are Saying

Laurie Porcaro
Diabetes Clinical Manager


Barbara McLean
MR, RN, CCNS-BC, NP-BC, CCRN, FC...
AFFILIATIONS & AWARDS










